-+ 0.00%
-+ 0.00%
-+ 0.00%

Indivior eliminates chief scientific officer role; Heidbreder departs end-2026

PUBT·05/15/2026 20:04:32
Listen to the news
Indivior eliminates chief scientific officer role; Heidbreder departs end-2026
  • Indivior will eliminate Chief Scientific Officer role effective June 1, 2026.
  • Christian Heidbreder will continue reporting to CEO in advisory role on special projects through end of 2026.
  • Heidbreder’s employment will end Dec. 31, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Indivior Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001625297-26-000024), on May 15, 2026, and is solely responsible for the information contained therein.